[
  {
    "ts": "2025-11-07T00:26:41+00:00",
    "headline": "Why IDEXX Laboratories (IDXX) Is Up 13.6% After Strong Q3 Results and Raised 2025 Guidance",
    "summary": "IDEXX Laboratories recently reported strong third-quarter results, with revenue of US$1,105.24 million and net income of US$274.61 million, as well as raising its full-year 2025 revenue and EPS guidance on the back of robust growth in Companion Animal Diagnostics and successful new product launches. The company also completed a buyback tranche repurchasing 411,180 shares for US$241.57 million in the quarter, highlighting continued commitment to capital returns amid expanding margins and...",
    "url": "https://finance.yahoo.com/news/why-idexx-laboratories-idxx-13-002641434.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "9a70e8cd-482d-3863-8095-9f1cc9f54598",
      "content": {
        "id": "9a70e8cd-482d-3863-8095-9f1cc9f54598",
        "contentType": "STORY",
        "title": "Why IDEXX Laboratories (IDXX) Is Up 13.6% After Strong Q3 Results and Raised 2025 Guidance",
        "description": "",
        "summary": "IDEXX Laboratories recently reported strong third-quarter results, with revenue of US$1,105.24 million and net income of US$274.61 million, as well as raising its full-year 2025 revenue and EPS guidance on the back of robust growth in Companion Animal Diagnostics and successful new product launches. The company also completed a buyback tranche repurchasing 411,180 shares for US$241.57 million in the quarter, highlighting continued commitment to capital returns amid expanding margins and...",
        "pubDate": "2025-11-07T00:26:41Z",
        "displayTime": "2025-11-07T00:26:41Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/c9a7292a91d7a765083b12facba6a3c6",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GXos2AI_E6PWjDrTZxAhqQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/c9a7292a91d7a765083b12facba6a3c6.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rpiKiLx6lpIm6oWrUz8z0g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/c9a7292a91d7a765083b12facba6a3c6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/why-idexx-laboratories-idxx-13-002641434.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-idexx-laboratories-idxx-13-002641434.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IDXX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]